OncoDNA: OncoXplore

OncoDNA has launched OncoXplore, a pan-cancer sequencing test for research that targets 635 cancer-related genes and evaluates biomarkers for precision oncology studies. The test analyzes FFPE tumor tissue or frozen tumor samples and reports tumor mutational burden, homologous repair deficiency, microsatellite instability, somatic mutations including SNPs and indels, and loss of heterozygosity. The NGS data are made available through the firm's cloud-based interactive Mercury software that enables the generation of customized reports.